Specific alteration of gene expression profile in rats by treatment with thyroid toxicants that inhibit thyroid...

Area of Science:

• Toxicogenomics
• Molecular Toxicology
• Biomarker Discovery

Background:

• Transcriptomics aids chemical risk assessment by predicting modes of action (MOAs) and identifying biomarkers.
• Understanding MOAs at a molecular level is crucial for chemical safety evaluation.
• Thyroid toxicity has distinct MOAs: direct inhibition of hormone synthesis and indirect hypermetabolism via liver enzyme induction.

Purpose of the Study:

• To differentiate direct and indirect MOAs of thyroid toxicity using transcriptomics.
• To identify characteristic gene expression profiles associated with thyroid peroxidase inhibition.
• To enhance the accuracy of MOA evaluation for thyroid toxicants.

Main Methods:

• Global gene expression profiling using microarrays in rats.
• Treatment with direct thyroid toxicants (e.g., propylthiouracil) and indirect toxicants (e.g., phenobarbital).
• Application of a subtraction method to identify differential gene expression patterns.

Main Results:

• Identified characteristic gene expression changes in the thyroid hormone synthesis pathway specific to direct-acting chemicals.
• Observed alterations in gene expression correlated with thyroid peroxidase inhibition.
• Demonstrated the utility of transcriptomics in distinguishing between direct and indirect thyroid toxicity MOAs.

Conclusions:

• Transcriptomics-based subtraction method effectively distinguishes direct thyroid toxicant MOAs.
• Identified gene expression signatures can serve as indicators of thyroid peroxidase inhibition.
• This approach offers a more precise evaluation of chemical MOAs for thyroid toxicity.